AR046170A1 - Derivados de pirimidin-2-amina y su uso como antagonistas del receptor de adenosina a 2b - Google Patents
Derivados de pirimidin-2-amina y su uso como antagonistas del receptor de adenosina a 2bInfo
- Publication number
- AR046170A1 AR046170A1 ARP040103547A ARP040103547A AR046170A1 AR 046170 A1 AR046170 A1 AR 046170A1 AR P040103547 A ARP040103547 A AR P040103547A AR P040103547 A ARP040103547 A AR P040103547A AR 046170 A1 AR046170 A1 AR 046170A1
- Authority
- AR
- Argentina
- Prior art keywords
- optionally substituted
- branched
- group
- linear
- substituted linear
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
El presente se refiere a procesos para su preparación; a composiciones farmacéuticas que los comprenden y a su uso en terapia. Reivindicación 1: Un compuesto de fórmula (1), en la que: R1 representa un grupo arilo o heteroarilo monocíclico o policíclico opcionalmente sustituido con uno, dos o tres sustituyentes seleccionados del grupo constituido por átomos de halógeno, alquilo inferior lineal o ramificado opcionalmente sustituido, hidroxi, alcoxi inferior lineal o ramificado opcionalmente sustituido, -SH, alquiltio inferior lineal o ramificado opcionalmente sustituido, nitro, ciano, -NR'R'', -CO2R', -C(O)-NR'R'', -N(R''')C(O)-R', -N(R''')-C(O)NR'R'', representando cada R', R'' y R''' independientemente un átomo de hidrógeno o un grupo alquilo inferior lineal o ramificado opcionalmente sustituido o R' y R'' junto con el átomo al que están unidos forman un grupo cíclico; R2 representa un grupo heteroarilo monocíclico que contiene N seleccionado del grupo de fórmulas (2), estando los grupos de fórmulas (2) opcionalmente sustituidos con uno, dos o tres sustituyentes seleccionados del grupo formado por átomos de halógeno, alquilo inferior opcionalmente sustituido lineal o ramificado, hidroxi, alcoxi opcionalmente sustituido lineal o ramificado, -SH, alquiltio opcionalmente sustituido lineal o ramificado, nitro, ciano, -NR'R'', -CO2R', -C(O)-NR'R'', -N(R''')C(O)-R', -N(R''')-C(O)NR'R'', en los que cada uno de R', R'' y R''' representa independientemente un átomo de hidrógeno o un grupo alquilo inferior opcionalmente sustituido lineal o ramificado o R' y R'' junto con el átomo al que están unidos forman un grupo cíclico; R3 representa un grupo heteroarilo monocíclico o policíclico que está opcionalmente sustituido con uno, dos o tres sustituyentes seleccionados del grupo de halógeno, alquilo inferior lineal o ramificado opcionalmente sustituido, hidroxi, oxo, alcoxi inferior lineal o ramificado opcionalmente sustituido, -SH, alquiltio inferior lineal o ramificado opcionalmente sustituido, nitro, ciano, -NR'R'', -CO2R', -C(O)-NR'R'', -N(R''')C(O)-R', -N(R''')-C(O)NR'R'', representando cada R', R'' y R''' independientemente un átomo de hidrógeno o un grupo alquilo lineal o ramificado opcionalmente sustituido o R' y R'' junto con el átomo al que están unidos forman un grupo cíclico; o un N-óxido o una sal farmacéuticamente aceptable del mismo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200302275A ES2229928B1 (es) | 2003-10-02 | 2003-10-02 | Nuevos derivados de pirimidin-2-amina. |
Publications (1)
Publication Number | Publication Date |
---|---|
AR046170A1 true AR046170A1 (es) | 2005-11-30 |
Family
ID=34507890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040103547A AR046170A1 (es) | 2003-10-02 | 2004-09-30 | Derivados de pirimidin-2-amina y su uso como antagonistas del receptor de adenosina a 2b |
Country Status (24)
Country | Link |
---|---|
US (1) | US20070265273A1 (es) |
EP (1) | EP1668000A1 (es) |
JP (1) | JP2007507443A (es) |
KR (1) | KR20060097010A (es) |
CN (1) | CN1886402A (es) |
AR (1) | AR046170A1 (es) |
AU (1) | AU2004283800B8 (es) |
BR (1) | BRPI0415324A (es) |
CA (1) | CA2540765A1 (es) |
CO (1) | CO5690593A2 (es) |
EC (1) | ECSP066426A (es) |
ES (1) | ES2229928B1 (es) |
IL (1) | IL174771A0 (es) |
MX (1) | MXPA06003525A (es) |
NO (1) | NO20061952L (es) |
NZ (1) | NZ546266A (es) |
PE (1) | PE20050473A1 (es) |
RU (1) | RU2006114746A (es) |
SG (1) | SG149077A1 (es) |
TW (1) | TW200526645A (es) |
UA (1) | UA82563C2 (es) |
UY (1) | UY28529A1 (es) |
WO (1) | WO2005040155A1 (es) |
ZA (1) | ZA200602139B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1799221A1 (en) | 2004-10-15 | 2007-06-27 | Cv Therapeutics, Inc. | Method of preventing and treating airway remodeling and pulmonary inflammation using a2b adenosine receptor antagonists |
ES2270715B1 (es) * | 2005-07-29 | 2008-04-01 | Laboratorios Almirall S.A. | Nuevos derivados de pirazina. |
ES2274712B1 (es) | 2005-10-06 | 2008-03-01 | Laboratorios Almirall S.A. | Nuevos derivados imidazopiridina. |
DE102006046410A1 (de) * | 2006-09-20 | 2008-03-27 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Arzneimittel zur Prophylaxe oder Behandlung oder Diagnostik von ischämischen Krankheiten |
ES2303776B1 (es) * | 2006-12-29 | 2009-08-07 | Laboratorios Almirall S.A. | Derivados de 5-fenil-6-piridin-4-il-1,3-dihidro-2h-imidazo(4,5-b)piridin-2-ona utiles como antagonistas del receptor de adenosina a2b. |
ES2320955B1 (es) | 2007-03-02 | 2010-03-16 | Laboratorios Almirall S.A. | Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida. |
KR20100020454A (ko) * | 2007-06-08 | 2010-02-22 | 바이엘 크롭사이언스 소시에떼아노님 | 살진균제 헤테로사이클릴-피리미디닐-아미노 유도체 |
AU2008278966B2 (en) * | 2007-07-26 | 2012-02-23 | Novartis Ag | Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
KR20120107538A (ko) | 2007-08-22 | 2012-10-02 | 아이알엠 엘엘씨 | 키나제 억제제로서의 5-(4-(할로알콕시)페닐)피리미딘-2-아민 화합물 및 조성물 |
BRPI0815572A2 (pt) * | 2007-08-22 | 2015-02-18 | Irm Llc | Compostos e composições como inibidores de quinases |
EP2108641A1 (en) | 2008-04-11 | 2009-10-14 | Laboratorios Almirall, S.A. | New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
EP2113503A1 (en) | 2008-04-28 | 2009-11-04 | Laboratorios Almirall, S.A. | New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors |
EP2308866A1 (de) | 2009-10-09 | 2011-04-13 | Bayer CropScience AG | Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide |
EP2322176A1 (en) | 2009-11-11 | 2011-05-18 | Almirall, S.A. | New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives |
AR079545A1 (es) | 2009-12-21 | 2012-02-01 | Bayer Cropscience Ag | Tienilpiri(mi)dinilazol |
CN103270026A (zh) | 2010-12-21 | 2013-08-28 | 诺瓦提斯公司 | 作为vps34抑制剂的联-杂芳基化合物 |
CN112608316B (zh) | 2019-07-30 | 2022-10-21 | 厦门宝太生物科技股份有限公司 | 一种吡唑并三嗪类腺苷受体拮抗剂 |
CN112592354B (zh) | 2019-07-30 | 2022-05-27 | 厦门宝太生物科技股份有限公司 | 一种异噁唑并嘧啶类杂环化合物的制备方法 |
CN115477653B (zh) * | 2022-10-11 | 2024-04-09 | 安徽省庆云医药股份有限公司 | 一种曲拉西利关键中间体及曲拉西利的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US22106A (en) * | 1858-11-23 | Truss-bridge | ||
US42891A (en) * | 1864-05-24 | Improvement in water-engines | ||
US275038A (en) * | 1883-04-03 | Ors to themselves | ||
US176399A (en) * | 1876-04-18 | Improvement in boxes for packing crackers | ||
US23763A (en) * | 1859-04-26 | Method of adjusting the knives of rotary cutter-heads for planing wood | ||
GB9309573D0 (en) * | 1993-05-10 | 1993-06-23 | Merck Sharp & Dohme | Therapeutic agents |
US5686470A (en) * | 1995-02-10 | 1997-11-11 | Weier; Richard M. | 2, 3-substituted pyridines for the treatment of inflammation |
US7189717B2 (en) * | 2000-04-26 | 2007-03-13 | Eisai Co., Ltd. | Medicinal compositions promoting bowel movement |
US6641549B2 (en) * | 2001-02-05 | 2003-11-04 | Bsn Medical, Inc. | Custom-moldable support for patellar tendinitis |
TWI330183B (es) * | 2001-10-22 | 2010-09-11 | Eisai R&D Man Co Ltd | |
US20050043315A1 (en) * | 2002-01-02 | 2005-02-24 | Hideo Tsutsumi | Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them |
-
2003
- 2003-10-02 ES ES200302275A patent/ES2229928B1/es not_active Expired - Fee Related
-
2004
- 2004-09-21 UY UY28529A patent/UY28529A1/es not_active Application Discontinuation
- 2004-09-22 UA UAA200604615A patent/UA82563C2/uk unknown
- 2004-09-22 WO PCT/EP2004/010644 patent/WO2005040155A1/en active Application Filing
- 2004-09-22 CA CA002540765A patent/CA2540765A1/en not_active Abandoned
- 2004-09-22 AU AU2004283800A patent/AU2004283800B8/en not_active Ceased
- 2004-09-22 ZA ZA200602139A patent/ZA200602139B/en unknown
- 2004-09-22 EP EP04765506A patent/EP1668000A1/en not_active Withdrawn
- 2004-09-22 JP JP2006530007A patent/JP2007507443A/ja active Pending
- 2004-09-22 BR BRPI0415324-3A patent/BRPI0415324A/pt not_active IP Right Cessation
- 2004-09-22 KR KR1020067006384A patent/KR20060097010A/ko not_active Application Discontinuation
- 2004-09-22 NZ NZ546266A patent/NZ546266A/en unknown
- 2004-09-22 RU RU2006114746/04A patent/RU2006114746A/ru not_active Application Discontinuation
- 2004-09-22 MX MXPA06003525A patent/MXPA06003525A/es unknown
- 2004-09-22 US US10/574,101 patent/US20070265273A1/en not_active Abandoned
- 2004-09-22 SG SG200809684-4A patent/SG149077A1/en unknown
- 2004-09-22 CN CNA2004800346926A patent/CN1886402A/zh active Pending
- 2004-09-28 PE PE2004000948A patent/PE20050473A1/es not_active Application Discontinuation
- 2004-09-30 TW TW093129574A patent/TW200526645A/zh unknown
- 2004-09-30 AR ARP040103547A patent/AR046170A1/es unknown
-
2006
- 2006-03-16 EC EC2006006426A patent/ECSP066426A/es unknown
- 2006-03-31 CO CO06032147A patent/CO5690593A2/es not_active Application Discontinuation
- 2006-04-03 IL IL174771A patent/IL174771A0/en unknown
- 2006-05-02 NO NO20061952A patent/NO20061952L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0415324A (pt) | 2006-12-05 |
IL174771A0 (en) | 2006-08-20 |
WO2005040155A8 (en) | 2006-04-20 |
CA2540765A1 (en) | 2005-05-06 |
WO2005040155A1 (en) | 2005-05-06 |
NO20061952L (no) | 2006-06-26 |
AU2004283800B2 (en) | 2009-05-07 |
AU2004283800B8 (en) | 2009-06-18 |
JP2007507443A (ja) | 2007-03-29 |
AU2004283800A1 (en) | 2005-05-06 |
ECSP066426A (es) | 2006-10-17 |
UA82563C2 (uk) | 2008-04-25 |
EP1668000A1 (en) | 2006-06-14 |
SG149077A1 (en) | 2009-01-29 |
ZA200602139B (en) | 2007-06-27 |
UY28529A1 (es) | 2005-04-29 |
CN1886402A (zh) | 2006-12-27 |
KR20060097010A (ko) | 2006-09-13 |
NZ546266A (en) | 2008-10-31 |
PE20050473A1 (es) | 2005-08-24 |
CO5690593A2 (es) | 2006-10-31 |
RU2006114746A (ru) | 2007-11-20 |
ES2229928B1 (es) | 2006-07-01 |
TW200526645A (en) | 2005-08-16 |
US20070265273A1 (en) | 2007-11-15 |
ES2229928A1 (es) | 2005-04-16 |
MXPA06003525A (es) | 2006-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR046170A1 (es) | Derivados de pirimidin-2-amina y su uso como antagonistas del receptor de adenosina a 2b | |
AR072906A1 (es) | Nucleosidos modificados utiles como antivirales | |
AR052943A1 (es) | Derivados de 2-(4-oxo-4h-quinazolin-3-il)acetamida | |
AR088029A1 (es) | Compuestos de pirimidina sustituidos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento del dolor, accidentes cerebrovasculares, epilepsia y otras enfermedades del sistema nervioso central | |
AR077328A1 (es) | Derivados de oxazina y su uso en el tratamiento de trastornos neurologicos | |
AR058073A1 (es) | Derivados de imidazol 5-il-pirimidina, procesos de obtencion, composiciones farmaceuticas y usos | |
CO5721006A2 (es) | Derivados de pirazolo-quinazolina, proceso para su preparacion y su uso como inhibidores de quinasa | |
AR079205A1 (es) | Morfolinotiazoles como moduladores alostericos positivos alfa 7 | |
AR060050A1 (es) | Compuestos moduladores del receptor de s1p y uso de los mismos | |
AR062360A1 (es) | Derivados heterociclicos que modulan la actividad de la estearoil-coa-desaturasa | |
ECSP099394A (es) | Derivados de quinuclidinol como antogonistas de receptores muscarínicos | |
AR044011A1 (es) | Antagonistas de mchr1 heterociclicos | |
AR078786A1 (es) | Derivados de la cromenona | |
AR065583A1 (es) | Compuestos macrociclicos y composicion farmaceutica | |
AR062503A1 (es) | Derivados de pirido[2, 3-d]pirimidina y pirazin[2, 3-d]pirimidina, composiciones farmaceuticas que los comprenden y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por la inhibicion de mtor. | |
AR048939A1 (es) | Derivados de fenol y tiofenol 3 - o 4 - monosustituidos utiles como ligandos de h3; composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos para el tratamiento de trastornos neurologicos e inflamatorios. | |
AR049333A1 (es) | Azaindoles inhibidores de proteinquinasas rock y otras proteinas quinasas. composiciones farmaceuticas. | |
CL2004000918A1 (es) | Compuestos derivados de quinuclidina, antagonistas del receptor muscarinico m3; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para tratar una condicion anti-inflamatoria o alergica, en particular de las vias respiratoria | |
AR088828A1 (es) | DERIVADOS DE CICLOHEXILAMINA QUE TIENEN ACTIVIDAD COMO AGONISTAS ADRENERGICOS b2 Y COMO ANTAGONISTAS MUSCARINICOS M3 | |
AR069804A1 (es) | Agonistas del receptor glucocorticoide c20- c21 sustituido | |
AR069435A1 (es) | Derivados de aminotiazol, proceso para la obtencion de los mismos, composiciones farmaceuticas y su uso como inhibidores de la fbpasa | |
AR060914A1 (es) | Derivados de furopiridina como ligandos receptores de la acetilcolina nicotinica, una composicion farmaceutica que los comprende y su empleo en la manufactura de un medicamento para el tratamiento de una enfermedad mediada por la activacion del receptor alfa7-nicotinico. | |
AR081932A1 (es) | Derivados de heteroaril imidazolona, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades neoplasicas y autoinmunes | |
AR048501A1 (es) | Compuesto de benzoazabicicloheptano dimerico, composicion farmaceutica que lo comprende y su uso para prepararla | |
CO6020016A1 (es) | Derivados de 1,2,4,5 tetrahidro-3h-benzapezinas su procedimiento de preparacion y las composiciones farmaceuticas que las contienen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |